Clinical Trial

Part 1: Dose-Finding of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users

Completed Phase 1
View on ClinicalTrials.gov →
Summary
Part 1: To determine the doses of IV HSK3486 and propofol for use in Part 2, the abuse potential part of the study. Part 2: To evaluate the abuse potential of HSK3486 compared with propofol when administered IV to healthy nondependent, recreational CNS depressant drug users.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-04.
Trial Details
NCT Number NCT07404306
Lead Sponsor Haisco-USA Pharmaceuticals, Inc.
Conditions General Anesthesia
Enrollment 43 participants
Start Date 2022-08-16
Primary Completion 2023-10-03 (estimated)
Study Completion 2023-10-03 (estimated)
Updated on ClinicalTrials.gov 2026-02-23